Dow Jones

40 003,59

0,34%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Oncobiologics, Inc. (delisted) (ONS)
Oncobiologics, Inc. (delisted) (ONS) Actualités

ONS

ONCOBIOLOGICS, INC. (ONS)

Oncobiologics, Inc. (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ONS

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
06/12/2018	23h10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
06/12/2018	22h18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
04/12/2018	23h53	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
09/11/2018	22h19	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
26/10/2018	22h59	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
17/08/2018	13h01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
14/08/2018	23h06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
07/08/2018	23h04	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
16/05/2018	22h09	Edgar (US Regulatory)	(25-NSE)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
17/04/2018	15h00	GlobeNewswire Inc.	Oncobiologics Appoints Randy Thurman to Board of Directors	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
02/04/2018	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
27/03/2018	22h23	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
27/03/2018	15h00	GlobeNewswire Inc.	Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
15/02/2018	23h32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
15/02/2018	23h31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
14/02/2018	15h00	GlobeNewswire Inc.	Oncobiologics Reports First Quarter Fiscal Year 2018 Results	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
13/02/2018	22h36	GlobeNewswire Inc.	Oncobiologics Receives Positive Nasdaq Listing Determination	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
09/02/2018	15h00	GlobeNewswire Inc.	Oncobiologics Announces Term Extension of Series A Warrants	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
30/01/2018	00h05	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
29/12/2017	22h20	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
31/10/2017	14h00	GlobeNewswire Inc.	Oncobiologics Announces Closing of Strategic Partnership Deal with GMS Tenshi Holdings	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
29/09/2017	22h12	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
27/09/2017	22h51	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
25/09/2017	22h48	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
25/09/2017	22h01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
18/09/2017	23h17	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
08/09/2017	14h31	GlobeNewswire Inc.	Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
15/08/2017	14h22	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
01/06/2017	15h00	GlobeNewswire Inc.	Oncobiologics Closes on Final Portion of $15 Million Senior Secured Note and Warrant Offering	NASDAQ:ONS	Oncobiologics, Inc. (delisted)
09/05/2017	15h00	GlobeNewswire Inc.	Oncobiologics to Present at the World Biosimilar Congress 2017	NASDAQ:ONS	Oncobiologics, Inc. (delisted)